Gian-Marco Rinaldi Diaz de la Cruz

Gian-Marco Rinaldi Diaz de la Cruz

Director/Board Member at NLS PHARMACEUTICS AG

Net worth: 37 890 $ as of 31/05/2024

51 year
Consumer Services
Health Technology
Miscellaneous

Network origin in Gian-Marco Rinaldi Diaz de la Cruz first degree

EntityEntity typeIndustry
Clariden Leu AG
24
Extinct Regional Banks 24
Public Company Pharmaceuticals: Major 17
3
Private Company Investment Trusts/Mutual Funds 3

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Gian-Marco Rinaldi Diaz de la Cruz via their personal network

CompanySectorRelated peopleMain position
Investment Managers

Nathalie Flury

Stefan K. Kraeuchi

Irene Beatrice Püttner

Alfonso Gomez Velasco

Sascha Braun

Christian Bruns

Hilary Paul

Martin Schlatter

Corporate Officer/Principal

Chief Investment Officer

Portfolio Manager-Equities

Portfolio Manager-Equities

Portfolio Manager-Equities

Portfolio Manager-Fixed Income

Portfolio Manager-Fixed Income

Portfolio Manager-Equities

University of Basel College/University

Nathalie Flury

Myoung-Ok Kwon

Carlos R. Camozzi

Ronald Hafner

Doctorate Degree

Doctorate Degree

Corporate Officer/Principal

Masters Business Admin

Investment Managers

Eric Henry Bernhardt

Scilla Huang Sun

Beat Wittmann

Corporate Officer/Principal

Head-Equity Investments

President

UBS Investment Managers

Eric Henry Bernhardt

Richard O. Ebner

Corporate Officer/Principal

Director/Board Member

Investment Managers

Nathalie Flury

Scilla Huang Sun

Portfolio Manager-Equities

Head-Equity Investments

Investment Managers

Sandro Rosa

Erich Pfister

Analyst-Equity

Head of Private Banking

Investment Managers

Eric Henry Bernhardt

Director of Research - Equity

Pharmaceuticals: Major

Carlos R. Camozzi

Chief Tech/Sci/R&D Officer

ORPHAZYME A/S Pharmaceuticals: Major

Carlos R. Camozzi

Chief Tech/Sci/R&D Officer

UNIQURE N.V. Biotechnology

Carlos R. Camozzi

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Carlos R. Camozzi

Corporate Officer/Principal

Pharmaceuticals: Major

Carlos R. Camozzi

Corporate Officer/Principal

Chemicals: Agricultural

Carlos R. Camozzi

Corporate Officer/Principal

Pharmaceuticals: Major

Carlos R. Camozzi

Corporate Officer/Principal

Roche Corp.

Carlos R. Camozzi

Corporate Officer/Principal

Household/Personal Care

Carlos R. Camozzi

Chief Tech/Sci/R&D Officer

Medical Specialties

Silvia Panigone

Director/Board Member

Hospital/Nursing Management

Carlos R. Camozzi

Chief Tech/Sci/R&D Officer

Investment Managers

Matthias Müller

Corporate Officer/Principal

Pharmaceuticals: Major

Silvia Panigone

Director/Board Member

Adya Consulting Sagl

Silvia Panigone

Chief Executive Officer

Internet Software/Services

Silvia Panigone

Corporate Officer/Principal

University of Milan College/University

Silvia Panigone

Undergraduate Degree

SDA Bocconi School of Management College/University

Silvia Panigone

Graduate Degree

Healthcapital SA

Silvia Panigone

Chief Investment Officer

Fondazione Irccs Istituto Nazionale Dei Tumori College/University

Silvia Panigone

Doctorate Degree

Universidad de Buenos Aires College/University

Carlos R. Camozzi

Doctorate Degree

Investment Managers

Holger G. Demuth

Director/Board Member

Investment Managers

Christian Bruns

Chief Investment Officer

Investment Managers

Audrey Greenberg

Director of Finance/CFO

Medical Specialties

Audrey Greenberg

Director/Board Member

Miscellaneous Commercial Services

Audrey Greenberg

Director/Board Member

King of Prussia District

Audrey Greenberg

Director/Board Member

Miscellaneous Commercial Services

Audrey Greenberg

Director/Board Member

Miscellaneous Commercial Services

Audrey Greenberg

Director/Board Member

Philadelphia Alliance For Capital & Technologies

Audrey Greenberg

Director/Board Member

Break Into The Boardroom

Audrey Greenberg

Director/Board Member

Investment Managers

Audrey Greenberg

Private Equity Investor

Finance/Rental/Leasing

Audrey Greenberg

Director of Finance/CFO

Investment Managers

Audrey Greenberg

Founder

Investment Managers

Christian Bruns

Portfolio Manager-Equities

MORGAN STANLEY Investment Managers

Audrey Greenberg

Corporate Officer/Principal

Miscellaneous Commercial Services

Audrey Greenberg

Corporate Officer/Principal

Investment Managers

Erich Pfister

Chief Executive Officer

Investment Managers

Erich Pfister

Head of Private Banking

Investment Managers

Erich Pfister

Chief Executive Officer

Investment Managers

Erich Pfister

Chief Executive Officer

Statistics

International

Switzerland 22
United States 18
United Kingdom 4
Italy 4
Netherlands 3

Sectoral

Finance 21
Health Technology 10
Consumer Services 6
Commercial Services 6
Process Industries 2

Operational

Director/Board Member 56
Corporate Officer/Principal 48
Portfolio Manager-Equities 32
Chairman 24
Chief Executive Officer 20